International Journal of Angiology最新文献

筛选
英文 中文
Investigation of the Survival Time of Patients Who Underwent Endovascular Treatment Due to Type 3 Aortic Dissection and Factors Affecting This Duration. 3型主动脉夹层患者行血管内治疗的生存时间及影响生存时间的因素分析。
IF 0.8
International Journal of Angiology Pub Date : 2025-07-02 eCollection Date: 2026-03-01 DOI: 10.1055/a-2640-0775
Mehmet Işık, Yalçın Günerhan, Ömer Tanyeli, Serkan Yıldırım, Ali Demiray
{"title":"Investigation of the Survival Time of Patients Who Underwent Endovascular Treatment Due to Type 3 Aortic Dissection and Factors Affecting This Duration.","authors":"Mehmet Işık, Yalçın Günerhan, Ömer Tanyeli, Serkan Yıldırım, Ali Demiray","doi":"10.1055/a-2640-0775","DOIUrl":"10.1055/a-2640-0775","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to analyze the survival time of patients who underwent thoracic endovascular aortic replacement (TEVAR) due to acute type 3 aortic dissection and to investigate comorbid conditions and dissection characteristics that affect survival time.</p><p><strong>Materials and methods: </strong>Between 2013 and 2023, 94 patients who underwent TEVAR for type 3 dissection were retrospectively investigated. Survival time and factors affecting this time (comorbidity and dissection characteristics) were analyzed.</p><p><strong>Results: </strong>The most common comorbidities were hypertension (88%). There was no significant difference between the demographic data of surviving and deceased patients. During the follow-up period, 57% of the patients survived, and 43% of the patients died. The mean survival time after TEVAR was 20.1 (0-108) months among patients who died and 47.7 (2-120) months for patients who lived. The mean number of comorbidities was 2.13 in patients who died and 2.25 in patients who survived. Survival distribution according to the type of interventional procedure was 50% for partial closure of the subclavian artery, 38.1% for complete closure, and 66.2% for closure starting from the distal subclavian artery ( <i>p</i>  = 0.06). Survival rate was significantly higher in patients who underwent reintervention ( <i>p</i>  = 0.005). Mortality was 9.5% in the early period, 25.5% in the first year, 29.7% in the second year, 34% in the third year, and 39.3% in the first 5 years.</p><p><strong>Conclusion: </strong>In our study, the survival rate was higher in patients who were followed regularly, and reintervention was applied when necessary. Therefore, we believe that undetected or untreated complications after TEVAR, rather than comorbid conditions, negatively affect survival more.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"35 1","pages":"64-70"},"PeriodicalIF":0.8,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12909083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146213067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pivotal Trials in Heart Failure in 2024-Putting Evidence into Clinical Practice! 2024年心力衰竭的关键试验——将证据投入临床实践!
IF 0.8
International Journal of Angiology Pub Date : 2025-07-01 eCollection Date: 2026-03-01 DOI: 10.1055/a-2624-5735
Prashant Thandi, Akshyaya Pradhan, Suresh Kumar Behera
{"title":"Pivotal Trials in Heart Failure in 2024-Putting Evidence into Clinical Practice!","authors":"Prashant Thandi, Akshyaya Pradhan, Suresh Kumar Behera","doi":"10.1055/a-2624-5735","DOIUrl":"10.1055/a-2624-5735","url":null,"abstract":"<p><p>The intricate interplay of physiological, psychological, and social factors presents considerable challenges in addressing heart failure. It is imperative to comprehend the epidemiology and pathophysiology, identify predictors and their influence on clinical outcomes, and effectively utilize the diagnostic tools. Such evidence is vital for formulating innovative therapeutic strategies to decelerate the growing heart failure epidemic. As of 2024, the field of heart failure has witnessed significant advancements in therapies applicable to both heart failure with preserved and reduced ejection fraction. Recent studies in this domain yielded valuable insights into the latest developments in cardiovascular medicine, which possess the potential to revolutionize treatment strategies. These advancements advocate for a more integrated approach to patient care and aim to enhance overall clinical outcomes. Below is a concise overview of key studies showcased at scientific meetings over the past year, which promise to improve heart failure management.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"35 1","pages":"1-9"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12909084/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146213095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aneurysmal Coronary Artery Disease: A Contemporary and Comprehensive Review. 动脉瘤性冠状动脉疾病:当代综合综述。
IF 0.8
International Journal of Angiology Pub Date : 2025-07-01 eCollection Date: 2025-12-01 DOI: 10.1055/a-2631-5355
Mohamad Mubder, Noyan Ramazani, Vasiliki Tasouli-Drakou, Nazanin Houshmand, Tahir Tak
{"title":"Aneurysmal Coronary Artery Disease: A Contemporary and Comprehensive Review.","authors":"Mohamad Mubder, Noyan Ramazani, Vasiliki Tasouli-Drakou, Nazanin Houshmand, Tahir Tak","doi":"10.1055/a-2631-5355","DOIUrl":"10.1055/a-2631-5355","url":null,"abstract":"<p><p>Coronary artery aneurysm (CAA) is a focal enlargement of the coronary artery exceeding 1.5 times the diameter of the adjacent normal segment of the vessel. The reported prevalence of CAA varies widely from 0.2 to 10%, with male predominance and a predilection for the right coronary artery. Atherosclerosis is the main cause in adults and Kawasaki disease in children. While often asymptomatic, CAA may present with angina, myocardial infarction, or possible fatal complications such as rupture, compression of adjacent cardiopulmonary structures, thrombus formation, and distal embolization. CAA is usually an incidental finding during coronary angiography; however, advancements in cardiac imaging have enhanced the detection and characterization of CAA. Coronary computed tomography angiography and magnetic resonance angiography offer alternatives to traditional approaches with high-resolution images that can help with risk stratification and management planning. Management varies based on the size, location, complications, and presence of symptoms. It includes medical therapy, percutaneous intervention, and surgical approach. In this paper, we aim to provide a comprehensive review of current knowledge of CAA and recent advances in its diagnosis and management.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 4","pages":"253-263"},"PeriodicalIF":0.8,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12591720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145481902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The History of Coronary Artery Disease. 冠状动脉疾病的历史
IF 0.8
International Journal of Angiology Pub Date : 2025-06-27 eCollection Date: 2025-12-01 DOI: 10.1055/a-2624-5607
Andrew J Gorton, Sibu P Saha
{"title":"The History of Coronary Artery Disease.","authors":"Andrew J Gorton, Sibu P Saha","doi":"10.1055/a-2624-5607","DOIUrl":"10.1055/a-2624-5607","url":null,"abstract":"<p><p>Coronary artery disease (CAD) is the leading cause of mortality worldwide and although often considered a modern disease its origins trace back to ancient civilizations. This historical review explores the evolution of understanding, diagnosis, and treatment of CAD. It will discuss early evidence of atherosclerosis in mummies through pioneers in the field of medical and surgical understanding to innovative surgical and interventional advances in the modern era. The progression of medical therapies, including the discovery and utilization of digitalis, nitrates, aspirin, beta blockers, and statins, is discussed alongside the evolution of catheter-based and surgical interventions such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Future therapies will be briefly discussed. Despite remarkable progress, CAD remains a major public health challenge, emphasizing the importance of continued innovation in prevention, diagnosis, and treatment. Understanding the historical trajectory of CAD provides critical insights for shaping the future of cardiovascular medicine.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 4","pages":"243-252"},"PeriodicalIF":0.8,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12591718/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145481919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coronary Stents: All Those Trials. 冠状动脉支架:所有的试验。
IF 0.8
International Journal of Angiology Pub Date : 2025-06-24 eCollection Date: 2025-12-01 DOI: 10.1055/a-2625-9999
Margaret Mary Glazier, James J Glazier
{"title":"Coronary Stents: All Those Trials.","authors":"Margaret Mary Glazier, James J Glazier","doi":"10.1055/a-2625-9999","DOIUrl":"10.1055/a-2625-9999","url":null,"abstract":"<p><p>In the nearly 40 years that have elapsed since the first coronary stent implantation in man, there has been a multitude of trials regarding this procedure. Stents were designed to combat two major weaknesses of balloon angioplasty: a high restenosis rate (>30%) and a 2 to 10% rate of abrupt closure. Early trials by some of the pioneers of the field suggested that stents, by scaffolding the artery, were indeed very successful in treating angioplasty-induced flow-limiting dissections. Findings of the BENESTENT-I (Belgian Netherlands stent trial) and STRESS (Stent Restenosis Study) demonstrated that stents reduced the restenosis rate to <30%. Drug-eluting stents were developed to further reduce the restenosis rates. In the SIRIUS trial (Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery), when compared with a bare metal stent, a sirolimus-eluting stent reduced significantly the need for revascularization of target lesions. Concerns regarding late and very late stent thrombosis with these first-generation drug-eluting stents led to the development of second-generation stents. Multiple trials have demonstrated very low stent thrombosis rates (<1%) with the latter stents. The promise of bioresorbable stents was dimmed by the findings of the ABSORB II trial (Bioresorbable Everolimus-Eluting Scaffold Versus a Metallic Everolimus-Eluting Stent). The findings of the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial suggests that the majority of patients with left main stem and three vessel coronary artery disease are better served by coronary artery bypass surgery rather than angioplasty with drug-eluting stents.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 4","pages":"303-311"},"PeriodicalIF":0.8,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12591716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145481965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unusual Incidence of Acute Type A Aortic Dissection during COVID-19. COVID-19期间急性A型主动脉夹层的异常发生率
IF 0.8
International Journal of Angiology Pub Date : 2025-05-23 eCollection Date: 2025-09-01 DOI: 10.1055/a-2594-4660
Ashley T Giammarino, John Winalski, Stevan S Pupovac, Frank Manetta, I Claire Sarmiento, Derek R Brinster
{"title":"Unusual Incidence of Acute Type A Aortic Dissection during COVID-19.","authors":"Ashley T Giammarino, John Winalski, Stevan S Pupovac, Frank Manetta, I Claire Sarmiento, Derek R Brinster","doi":"10.1055/a-2594-4660","DOIUrl":"10.1055/a-2594-4660","url":null,"abstract":"<p><p>Seasonal variations have been identified in the incidence of Stanford acute type A aortic dissection (ATAAD), and these have been only further impacted by the recent COVID-19 pandemic. We sought to examine the incidence and presentation of ATAAD during the initial height of the COVID-19 pandemic during the year 2020 and compare this with our pre-pandemic experience. A retrospective review was undertaken of all consecutive patients who had ATAAD repair between January 2014 and December 2020. The incidence and pattern of presentation during 2020 was compared with that of the prior 6 years. A total of 339 patients underwent ATAAD during the study period, 301 (88.8%) from 2014 to 2019 (pre-COVID-19) and 38 (11.2%) during 2020 (coincident with COVID-19). We found a marked decrease in the incidence of ATAAD during COVID-19 as compared to the aggregate of our prior experience. During the height of the COVID-19 pandemic, we witnessed significantly fewer patients presenting with ATAAD, presumably due to a combination of \"lockdown\" restrictions, perhaps coupled with reduced influenza activity in the population. This was followed by an unusual rebound in the incidence of ATAAD, a phenomenon not previously noted.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 3","pages":"215-219"},"PeriodicalIF":0.8,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324852/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144794360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Doppler Flowmeter Aids in Successful Pediatric Arteriovenous Fistula Repair. 多普勒流量计在成功的儿科动静脉瘘修复中的帮助。
IF 0.8
International Journal of Angiology Pub Date : 2025-05-21 eCollection Date: 2026-06-01 DOI: 10.1055/a-2594-4725
Kazuki Tanimoto, Keisuke Miyake, Takashi Kido, Masaki Taira, Shigeru Miyagawa
{"title":"Doppler Flowmeter Aids in Successful Pediatric Arteriovenous Fistula Repair.","authors":"Kazuki Tanimoto, Keisuke Miyake, Takashi Kido, Masaki Taira, Shigeru Miyagawa","doi":"10.1055/a-2594-4725","DOIUrl":"10.1055/a-2594-4725","url":null,"abstract":"<p><p>Detecting residual arteriovenous fistula (AVF) in small children is challenging. We report a case of a pediatric patient who required a reoperation for an iatrogenic femoral AVF due to an undetected residual AVF during the initial operation. Using a bidirectional Doppler volume flowmeter was helpful in ensuring complete resection. A 4-year-old girl with univentricular congenital heart disease and multiple surgeries for univentricular repair was referred for an iatrogenic right femoral AVF after several diagnostic and therapeutic catheterizations. Angiography before Fontan operation revealed the AVF, necessitating surgical intervention concomitantly. Initially, the AVF was ligated, and no residual AVF was detected by palpation. However, 1 year later, angiography and duplex ultrasound showed a residual AVF, causing a hemodynamic burden. Concerns about potential leg length discrepancy and elevated inferior vena cava pressure led to a reoperation. The AVF was divided: ligated, transected, and oversewn. Postoperative Doppler confirmed the absence of turbulent flow and normalized blood flow patterns. She had an uneventful recovery and was discharged the next day. Two weeks later, duplex ultrasound confirmed no residual AVF, with normalized blood flow in the right external iliac artery.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"35 2","pages":"139-142"},"PeriodicalIF":0.8,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13171193/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147941381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of Right Ventricular Echocardiography on Mortality in Intermediate-Risk Hispanic Patients with Acute Pulmonary Embolism. 右心室超声心动图对中危西班牙裔急性肺栓塞患者死亡率的预后价值。
IF 0.8
International Journal of Angiology Pub Date : 2025-05-19 eCollection Date: 2025-09-01 DOI: 10.1055/a-2594-4590
Aditi Kothari, Alok K Dwivedi, Debabrata Mukherjee, Manu Rajachandran, Nils P Nickel
{"title":"Prognostic Value of Right Ventricular Echocardiography on Mortality in Intermediate-Risk Hispanic Patients with Acute Pulmonary Embolism.","authors":"Aditi Kothari, Alok K Dwivedi, Debabrata Mukherjee, Manu Rajachandran, Nils P Nickel","doi":"10.1055/a-2594-4590","DOIUrl":"10.1055/a-2594-4590","url":null,"abstract":"<p><p>There is an underrepresentation of Hispanic patients in studies examining right ventricular (RV) function in acute pulmonary embolism (PE). Although the prognostic value of RV dysfunction in acute PE is well established, there is no generalized definition of RV dysfunction. In this study, our aim was to identify echocardiographic parameters that predict short-term mortality in Hispanic patients with intermediate-risk acute PE. This study aimed to determine clinical and echocardiographic predictors of mortality in Hispanic patients with intermediate-risk PE. We retrospectively studied a cohort of Hispanic patients with acute PE diagnosed on computed tomography angiography and classified as intermediate-risk based on either imaging findings or biomarker elevation. We identified 419 patients. The mean age was 58, and 53% were females. Forty (9.5%) patients died during the 30-day follow-up. Non-survivors had a higher Pulmonary Embolism Severity Index (PESI) score (101 ± 19.4, <i>p</i>  < 0.001), a higher incidence of diabetes, chronic kidney disease, end-stage renal disease, malignancy, and previous history of venous thromboembolism. On echocardiogram, non-survivors had an increased right ventricular end-diastolic area (32.7 ± 9 cm <sup>2</sup> ), higher right ventricular to left ventricular ratio (RV/LV, 0.75 ± 0.15), elevated right ventricular systolic pressure (RVSP, 42.4 ± 8.24), reduced right ventricular fractional area change (RVFAC, 24.03 ± 7.6), and reduced lateral tricuspid annular peak systolic velocity (TR max Vel S', 9.39 ± 2.2). In Hispanic patients with acute intermediate-risk PE, increased RV afterload (RVSP), RV dilation (RVDa, RV/LV ratio), and reduced RV systolic function (tricuspid annular plane systolic excursion, S', RVFAC) are the most important predictors of poor short-term outcome.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 3","pages":"191-200"},"PeriodicalIF":0.8,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144794358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome of Redo Endovascular Interventions in Cases of Infra-inguinal Arterial Occlusive Disease. 重做血管内介入治疗腹股沟下动脉闭塞性疾病的疗效。
IF 0.8
International Journal of Angiology Pub Date : 2025-05-07 eCollection Date: 2025-09-01 DOI: 10.1055/a-2572-1026
Khaled Mohamed Fekry, Sherif Balbaa, Ahmed Saeed, Ahmed Alaa Shaker
{"title":"Outcome of Redo Endovascular Interventions in Cases of Infra-inguinal Arterial Occlusive Disease.","authors":"Khaled Mohamed Fekry, Sherif Balbaa, Ahmed Saeed, Ahmed Alaa Shaker","doi":"10.1055/a-2572-1026","DOIUrl":"10.1055/a-2572-1026","url":null,"abstract":"<p><p>The aim was to assess the outcomes of different redo endovascular interventions in terms of wound healing and limb salvage within 6 months. From April 2024 to October 2024, a prospective clinical study was carried out on 56 patients who presented with chronic limb-threatening ischemia (CLTI) after previous peripheral endovascular intervention 6 months to 1 year earlier. Regarding technical success, restored linear blood flow from common femoral artery (CFA) to foot was higher in stenting and drug-coated balloon (DCB) than plain old balloon angioplasty (POBA) ( <i>p</i> value = 0.032 and 0.033 respectively). Restoration of pedal pulse was statistically higher in DCB than in stenting ( <i>p</i> value = 0.006) and higher in stenting than POBA ( <i>p</i> value = 0.003). Wound healing at time frame of 3 months after the operation was statistically higher in DCB than POBA and stenting ( <i>p</i> value = 0.002 and 0.007 respectively) and higher in stenting than POPA ( <i>p</i> value = 0.033). Regarding amputation-free survival, above ankle amputation within 6 months of follow-up was lower in stenting and DCB than POBA ( <i>p</i> value = 0.016 and 0.018 respectively) and there was no statistical difference between stenting and DCB ( <i>p</i> value = 0.166). Stenting and DCBs have demonstrated a superior ability than POBA to restore linear blood flow from the CFA to the foot, leading to better amputation-free survival rates, including a decreased likelihood of above ankle amputation within the first 6 months of follow-up. When it comes to wound healing and sustaining limb-based patency, DCB angioplasty has shown better performance compared with stenting and POBA.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 3","pages":"201-210"},"PeriodicalIF":0.8,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144794357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical Thrombectomy and Catheter-Directed Lysis in Treating Intermediate-Risk Pulmonary Embolization: 30-Day Outcome. 机械取栓和导管引导溶栓治疗中度危险肺栓塞:30天的结果。
IF 0.8
International Journal of Angiology Pub Date : 2025-05-02 eCollection Date: 2025-09-01 DOI: 10.1055/a-2577-2385
Nicolas W Shammas, William Sharis, George Mankarious, Yoshitha Inala, Morgan J Janes, Gail Shammas, Sue Jones-Miller, Cara Voelliger
{"title":"Mechanical Thrombectomy and Catheter-Directed Lysis in Treating Intermediate-Risk Pulmonary Embolization: 30-Day Outcome.","authors":"Nicolas W Shammas, William Sharis, George Mankarious, Yoshitha Inala, Morgan J Janes, Gail Shammas, Sue Jones-Miller, Cara Voelliger","doi":"10.1055/a-2577-2385","DOIUrl":"10.1055/a-2577-2385","url":null,"abstract":"<p><p>Intermediate risk pulmonary embolism (IRPE) is defined as dilatation of the right ventricular (RV) and evidence of myocardial necrosis with stable hemodynamics in the setting of acute PE. The differences in performance among the various devices in treating IRPE remain unclear. We reviewed consecutive patients treated at 2 medical centers between January 1, 2019, and December 31, 2022, using PMC devices (FlowTriever [Inari Medical] or Ekos [Boston Scientific]). Demographics, clinical, procedural variables, in-hospital complications, and 30-day outcomes were recorded from patients' medical records. Descriptive analyses were performed. The study's primary endpoint was the mean change in the RV/LV ratio. Safety endpoints included procedural complications 30-day mortality and major bleeding. 97 consecutive patients (43 FlowTriever, 54 Ekos) were included. The mean age was 64.16 ± 13.37 years. When compared with pretreatment, PMC reduced significantly the RV/LV ratio (0.55 ± 0.49, 95% CI: 0.40, 0.71, <i>p</i>  < 0.0001) and PA pressures (17.98 ± 14.72 mm Hg, 95% CI:10.88, 25.07, <i>p</i>  < 0.0001) with no differences seen between the FlowTriever and Ekos. At 30-day, all-cause mortality and major bleeding were 5.2 and 7.2%, respectively, and were similar between the FlowTriever and Ekos, respectively (4.7% vs. 5.6% ( <i>p</i>  = 0.935) and 7.0% vs. 7.4% ( <i>p</i>  = 0.935)). The Ekos, however, had a shorter procedure time, and less fluoroscopy and contrast use. PMC devices reduced significantly the RV/LV ratio and PA pressures when compared with the baseline. No differences were seen between the FlowTriever and Ekos. Thirty-day mortality and major bleeding were statistically similar between the two devices.</p>","PeriodicalId":13798,"journal":{"name":"International Journal of Angiology","volume":"34 3","pages":"169-175"},"PeriodicalIF":0.8,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144794356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书